Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
770 studies found for:    SOMATROPIN
Show Display Options
Rank Status Study
1 Active, not recruiting A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: Somatropin
2 Withdrawn Surveillance of Treatment of Children With Growth Hormone Deficiency With Zomacton®
Condition: Growth Hormone Deficiency
Intervention: Drug: Somatropin
3 Not yet recruiting Early hGH Treatment of SGA Infants to Prevent Irreversible Neurologic and Psychological Damage and Sequelae
Conditions: Infant, Small for Gestational Age;   Growth Hormone Treatment;   Infant, Premature, Diseases
Intervention: Drug: Human growth hormone,ZOMACTON® (somatropin)
4 Recruiting Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: PEG-somatropin
5 Terminated
Has Results
Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity Study
Condition: Growth Hormone Deficiency (GHD)
Intervention: Drug: Saizen®
6 Completed
Has Results
Drug Use Investigation of Somatropin for GHD-ADULTS.
Condition: Dwarfism, Growth Hormone Deficiency
Intervention: Drug: Somatropin
7 Completed Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children
Condition: Growth Hormone Deficiency
Interventions: Drug: somatropin AQ;   Drug: pegylated somatropin
8 Completed
Has Results
An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD)
Condition: Adult Growth Hormone Deficiency
Intervention: Drug: Saizen® solution for injection (referred as Saizen®)
9 Completed Evaluation of Overall Compliance and Duration of Zomacton® Treatment With the Zomajet® Needle-free Device
Conditions: Turner's Syndrome;   Human Growth Hormone Deficiency
Intervention: Drug: Somatropin
10 Terminated
Has Results
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Condition: Growth Hormone Deficiency
Interventions: Device: NuSpin;   Drug: Somatropin
11 Completed Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children
Condition: Growth Hormone Deficiency
Intervention: Biological: PEG-somatropin
12 Completed
Has Results
Long Term Use of Somatropin in Patients Small for Gestational Age
Condition: Small for Gestational Age
Intervention: Drug: Somatropin
13 Completed Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Pegylated-Somatropin in Healthy Volunteers
Condition: Healthy
Interventions: Drug: Pegylated-Somatropin;   Drug: YPEG-Somatropin
14 Completed
Has Results
Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
Condition: Growth Hormone Deficiency (GHD)
Interventions: Drug: ACP-001;   Drug: Human Growth Hormone
15 Completed Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children
Conditions: Growth Hormone Disorder;   Pituitary Dwarfism
Intervention: Drug: somatropin
16 Recruiting Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Condition: Pediatric Growth Hormone Deficiency
Interventions: Drug: MOD-4023;   Drug: Somatropin
17 Completed Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Condition: Pediatric Growth Hormone Deficiency
Interventions: Drug: MOD-4023;   Drug: Somatropin
18 Terminated
Has Results
Clinical Trial of Growth Hormone in MPS I, II, and VI
Conditions: Mucopolysaccharidosis I;   Mucopolysaccharidosis II;   Mucopolysaccharidosis VI
Intervention: Drug: Somatropin (DNA origin)
19 Completed Safety and Efficacy of Long-term Somatropin Treatment in Adults
Conditions: Growth Hormone Disorder;   Adult Growth Hormone Deficiency
Intervention: Drug: somatropin
20 Completed Diurnal Variation of Exogenous Peptides (GH Puls/Jurgita I)
Condition: Growth Hormone Deficiency
Intervention: Drug: Norditropin SimpleXx (growth hormone)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.